Effect of hepatic impairment on the pharmacokinetics of ripretinib.

Li, XY; Psoinos, CM; Shelton, MJ; Abane, F; Matson, MA; Oberstein, S; Ruiz-Soto, R

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16): E16031